GLIPR2 and prostate adenocarcinoma: In MEXPRESS database, changes in methylation sites cg06484397 (R = -0.115) and cg13644528 (R= -0.272) in LUAD were negatively correlated with GLIPR2 expression, while in PRAD, methylation at cg13644528 (R= -0.166) showed a negative correlation with GLIPR2 expression (Figures 3G–I).